American Century Companies
HRMY icon

American Century Companies’s Harmony Biosciences HRMY Stock Holding History

American Century Companies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.5M Buy
2,539,512
+434,333
+21% +$13.7M 0.04% 540
2026
Q1 		$59M Buy
2,105,179
+263,507
+14% +$8.64M 0.03% 674
2025
Q4 		$68.9M Buy
1,841,672
+172,107
+10% +$5.66M 0.03% 574
2025
Q3 		$46M Buy
1,669,565
+168,145
+11% +$5.79M 0.02% 744
2025
Q2 		$47.4M Buy
1,501,420
+212,633
+16% +$6.84M 0.03% 699
2025
Q1 		$42.8M Buy
1,288,787
+186,183
+17% +$6.67M 0.03% 689
2024
Q4 		$37.9M Buy
1,102,604
+246,140
+29% +$8.46M 0.02% 745
2024
Q3 		$34.3M Buy
856,464
+174,928
+26% +$6.14M 0.02% 779
2024
Q2 		$20.6M Buy
681,536
+238,140
+54% +$7.16M 0.01% 949
2024
Q1 		$14.9M Buy
443,396
+236,977
+115% +$7.61M 0.01% 1042
2023
Q4 		$6.67M Buy
206,419
+810
+0.4% +$22.6K ﹤0.01% 1303
2023
Q3 		$6.74M Sell
205,609
-267,431
-57% -$9.28M 0.01% 1223
2023
Q2 		$16.6M Sell
473,040
-141,801
-23% -$4.9M 0.01% 842
2023
Q1 		$20.1M Sell
614,841
-38,441
-6% -$1.75M 0.02% 748
2022
Q4 		$36M Sell
653,282
-60,583
-8% -$3.33M 0.03% 517
2022
Q3 		$31.6M Buy
713,865
+57,919
+9% +$2.83M 0.03% 512
2022
Q2 		$32M Buy
655,946
+89,638
+16% +$4.04M 0.03% 528
2022
Q1 		$27.6M Buy
566,308
+90,484
+19% +$3.69M 0.02% 612
2021
Q4 		$20.3M Buy
475,824
+287,013
+152% +$11.4M 0.01% 699
2021
Q3 		$7.24M Buy
188,811
+70
+0% +$2.25K 0.01% 926
2021
Q2 		$5.33M Buy
188,741
+37,650
+25% +$1.13M ﹤0.01% 975
2021
Q1 		$4.99M Buy
151,091
+32,542
+27% +$1.14M ﹤0.01% 940
2020
Q4 		$4.29M Buy
118,549
+17,337
+17% +$700K ﹤0.01% 909
2020
Q3 		$3.43M Buy
+101,212
New +$3.69M ﹤0.01% 855

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

American Century Companies's HRMY Position: Q2 2026 in Review

American Century Companies increased its Harmony Biosciences (HRMY) stake by 21% in Q2 2026, buying an estimated $13.7M and bringing the position to 2,539,512 shares worth $92.5M. The position accounts for 0.04% of the portfolio, ranked #540.

American Century Companies first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • American Century Companies held 2,539,512 shares of Harmony Biosciences worth $92.5M as of Q2 2026.
  • American Century Companies bought 434,333 Harmony Biosciences shares in Q2 2026, an estimated $13.7M.
  • Harmony Biosciences made up 0.04% of American Century Companies's portfolio in Q2 2026, its #540 holding.
  • American Century Companies first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.